These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36400770)

  • 1. An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation.
    Seuma M; Lehner B; Bolognesi B
    Nat Commun; 2022 Nov; 13(1):7084. PubMed ID: 36400770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.
    Seuma M; Faure AJ; Badia M; Lehner B; Bolognesi B
    Elife; 2021 Feb; 10():. PubMed ID: 33522485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without increasing protofibril formation.
    Hori Y; Hashimoto T; Wakutani Y; Urakami K; Nakashima K; Condron MM; Tsubuki S; Saido TC; Teplow DB; Iwatsubo T
    J Biol Chem; 2007 Feb; 282(7):4916-4923. PubMed ID: 17170111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.
    Hatami A; Monjazeb S; Milton S; Glabe CG
    J Biol Chem; 2017 Feb; 292(8):3172-3185. PubMed ID: 28049728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
    Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
    ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of pathogenic amyloid β-peptide in familial Alzheimer's disease.
    Wolfe MS
    Prog Mol Biol Transl Sci; 2019; 168():71-78. PubMed ID: 31699328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
    PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential for amyloid surface inhibitor: only amyloid-β oligomers formed by secondary nucleation disrupt lipid membrane integrity.
    Tian Y; Liu J; Yang F; Lian C; Zhang H; Viles JH; Li Z
    FEBS J; 2022 Nov; 289(21):6767-6781. PubMed ID: 35670622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.
    Wildburger NC; Esparza TJ; LeDuc RD; Fellers RT; Thomas PM; Cairns NJ; Kelleher NL; Bateman RJ; Brody DL
    Sci Rep; 2017 Aug; 7(1):9520. PubMed ID: 28842697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.
    Krone MG; Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
    J Mol Biol; 2008 Aug; 381(1):221-8. PubMed ID: 18597778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
    Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.